Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
170M
-
Number of holders
-
88
-
Total 13F shares, excl. options
-
18.8M
-
Shares change
-
+1.97M
-
Total reported value, excl. options
-
$547M
-
Value change
-
+$53.8M
-
Put/Call ratio
-
3.87
-
Number of buys
-
63
-
Number of sells
-
-20
-
Price
-
$29.05
Significant Holders of Seres Therapeutics, Inc. - COMMON STOCK (MCRB) as of Q2 2016
101 filings reported holding MCRB - Seres Therapeutics, Inc. - COMMON STOCK as of Q2 2016.
Seres Therapeutics, Inc. - COMMON STOCK (MCRB) has 88 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.8M shares
of 170M outstanding shares and own 11.04% of the company stock.
Largest 10 shareholders include FMR LLC (5.93M shares), FEDERATED INVESTORS INC /PA/ (1.99M shares), VANGUARD GROUP INC (1.18M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.15M shares), BlackRock Fund Advisors (927K shares), WADDELL & REED FINANCIAL INC (735K shares), JENNISON ASSOCIATES LLC (671K shares), BRIDGER MANAGEMENT, LLC (624K shares), TimesSquare Capital Management, LLC (491K shares), and ALLIANCEBERNSTEIN L.P. (417K shares).
This table shows the top 88 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.